Despite the lack of differences in cognitive function observed between groups, the study found that the subjects with DNP were more frequently under treatment with insulin, suffered from worse obesity and dyslipidaemia, had higher levels of anxiety and depression, worse quality of sleep and more frequently took medication for sleep, pain and drugs that affected cognition than the patients without DNP. The gene discussed is INS; the disease is Anxiety.